Page 15 - MedTech 1920_29Oct
P. 15

SINGAPORE MEDTECH DIRECTORY 2019/2020
Headed by the institute’s director Professor Lim Chwee Teck, HealthTEC is developing health and wellness solutions in two areas:
• Health sensing technologies, which refer to innovations to track and collect health-related data, and
• Health analytics and AI, which uses predictive modelling and machine learning technologies to make sense of collected data, with the aim of providing insights and suggesting actions that individuals can take to improve their own health and wellness.
The consortium will partner companies of all sizes based in Singapore, from start-ups to multinational companies. Companies that have joined the consortium as founding industry members include Roceso Technologies, Tip Biosystems, ST Engineering and Ferrero Asia Paci c.
At its 6,706-sq. metre technology centre in Tuas, Advanced MedTech Holdings, the largest medical device manufacturer in South-east Asia, is fostering collaboration within the group.
technologies, (the centre) will house design, digital innovation and healthcare, as well as facilities and spaces for co-creation and prototyping. (The centre’s) work will help bring together different stakeholders, including start- ups and entrepreneurs, to develop and test-bed integrated, next-generation healthcare solutions. More importantly, entrepreneurs and corporations can take advantage of this environment to learn from the experiences of the group’s management team, as they prepare to commercialise their technologies globally.”
Over the past four years, Advanced MedTech, formerly known as Accuron MedTechGroup,hasinvestedinover10 companies, most of which are related to its core urology business.
AWAK Technologies is the  rst portfolio company to move its
headquarters to the new centre. As a development stage company, it has access to the centre’s clean room manufacturing and assembly facility to support its research, development, manufacturing and commercial activities.
The opening of the technology centre is aligned with Advanced MedTech’s strategy to make future investments in deep-technology start-ups. Earlier in the year, Advanced MedTech also announced a co-investment of S$20 million together with SEEDS Capital to identify and catalyse the growth of high-potential Singapore- based start-ups.
Driven by megatrends, the MedTech industryiscontinuingtoexpandacross Asia. With its strong research base, clustering of healthcare innovation activities and deep manufacturing capabilities, Singapore is ideally placed to harness the region’s growth opportunities.
Pharmaceuticals
Biomedical Manufacturing Cluster
Biomedical Manufacturing Output 2014-2018 (S$M)
2014
16,891.3
Medical
SpeakingattheopeningofAdvancedTechnology 13,287.0
MedTech’s new technology centre in September 2018, Mr S. Iswaran, Minister for Communications and Information, said, “As an incubator for new disruptive
Source: Singapore Economic Development Board
p -preliminary
11,285.7
28,177.0
2015
16,721.2
10,134.6
26,855.8
2016
17,744.8
11,521.9
29,266.7
2017
17,109.0
12,373.6
29,482.7
2018 (p)
21,155.1
34.442.1
13


































































































   13   14   15   16   17